If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
265.00    -2.50 (-0.93%)
Bid:
260.00
Ask:
270.00
Spread: 10.00 (3.846%)
Market Cap: £240.73m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Update

2 Sep 2015 09:05

RNS Number : 7570X
Concurrent Technologies PLC
02 September 2015
 

02 September 2015

Concurrent Technologies Plc

 

Product Update

Next generation 3U VPXTM board featuring newly launched processor

 

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, is pleased to announce the launch of their first single board computer, a TR E5x/msd, based on the new Intel® Xeon® processor E3 family.

 

The TR E5x/msd features a quad core Intel® Xeon® processor with up to 16 Gbytes of DRAM and a rich assortment of I/O interfaces. With further improved processing and graphics performance and a wider range of configuration options than previous products, the TR E5x/msd is particularly suited to high-end multi-processor applications such as Command, Control, Communications, Computers, Intelligence, Surveillance and Reconnaissance applications within the defence market which is an important contributor to the Company's revenues. The product is expected to appeal to both existing and new customers within the defence market as well as the aerospace and transportation markets.

 

Initial shipments of air-cooled variants will be followed by rugged conduction-cooled modules, once the necessary qualifications are complete, ensuring this product will appeal to applications within both benign and harsh environments.

 

Glen Fawcett, CEO, Concurrent Technologies Plc, commented:

"We are excited to introduce our first new generation Intel® Xeon® processor based board. We are committed to delivering high quality embedded computers utilising the latest processors from Intel to advance our Size, Weight and Power (SWAP) propositions. The VPX form-factor is a popular choice and the new board complements our existing range of processor boards, switches, mass storage, I/O expansion carriers and development systems to provide a straightforward path from prototype to deployment."

 

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

Newgate (Financial PR)Tim Thompson

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

Nick Tulloch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using mainly Intel® processors, including the latest generation Intel® Core™ i7 processors, Intel® Xeon® and Intel® Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments. Other processors now include NVIDIA® Tegra® K1 devices.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLBMATMBTMBAA
Date   Source Headline
12th Sep 20187:00 amRNSInterim Results
6th Sep 20187:00 amRNSNotification of Interim Results
8th Jun 20187:00 amRNSProduct Announcement
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.